Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia

MeSH terms

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Factor VIIa / administration & dosage*
• Female
• Hemorrhage* / chemically induced
• Hemorrhage* / drug therapy
• Humans
• Lymphoproliferative Disorders / drug therapy*
• Male
• Middle Aged
• Recombinant Proteins / administration & dosage
• Thrombocytopenia* / chemically induced
• Thrombocytopenia* / drug therapy